$MGRX
Mangoceuticals, Inc. Common Stock
XNAS•Health Care•Services-Misc Health & Allied Services, Nec
Why is MGRX up today? It is at $0.511 (+20.18%), and our scanner flagged it 165 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MGRX spikes, and full due diligence on MGRX — key stats, earnings, dilution and insider activity. Free.
Get free $MGRX alerts the moment volume spikes
Our scanner flagged $MGRX 165 times in the last 30 days. Create a free account to track $MGRX, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $0.511
- Change today
- +20.18%
- Previous close
- $0.425
- 52-week range
- $0.162 – $2.75
- Market cap
- $7M
- Institutional own.
- 7.82%
- Total held
- 7.8%
- Tradeable float
- 15.8M 92% of shares · after 8% institutions
- Short interest
- 208K ▼ -46% vs prior · as of 2026-07-15
- Short % of float
- 1.3%
- Days to cover
- 1.0d
- Avg daily volume
- 6.6M
- Next earnings
- Aug 13 · in 7d
- Sector
- Health Care
- Industry
- Services-Misc Health & Allied Services, Nec
- Exchange
- XNAS
- 5m
- 1.1x
- 15m
- 0.9x
- 1h
- 0.4x
- 1D
- 68x
Get free MGRX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $MGRX up today?
MGRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 18 unusual-volume and momentum alerts on MGRX today, peaking at 23.0x its normal volume. Fresh from the SEC: MANGOCEUTICALS, INC. filed a Merger / acquisition communication (425). A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystMerger / acquisition communication (425), from the latest SEC filing. Read it →Insiders
0 buys, 0 sells last 3 months (5/4 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Johnston Eugene M Officer | Sold (automatic/other) | -3K 0.02% of company | sold 2.7% | 120K | $4K at $1.17 | Dec 15, 25 |
Johnston Eugene M Officer | Sold (automatic/other) | -5K 0.03% of company | sold 3.9% | 123K | $6K at $1.20 | Dec 9, 25 |
Johnston Eugene M Officer | Sold (automatic/other) | -10K 0.06% of company | sold 7.2% | 128K | $11K at $1.13 | Dec 5, 25 |
Hamilton Alex P. Director | Sold (automatic/other) | -125K 0.7% of company | sold 97% | 3K | $153K at $1.22 | Nov 19, 25 |
D'Alessio Lorraine Pamela Director | Acquired (grant/award) | +100K 0.6% of company | added 100% | 137K | n/a | Sep 9, 25 |
Myers Kenny Director | Acquired (grant/award) | +100K 0.6% of company | added 100% | 137K | n/a | Sep 9, 25 |
Hamilton Alex P. Director | Acquired (grant/award) | +100K 0.6% of company | added 100% | 127K | n/a | Sep 9, 25 |
Johnston Eugene M Officer | Acquired (grant/award) | +100K 0.6% of company | added 100% | 138K | n/a | Sep 9, 25 |
Cohen Jacob D. Officer | Acquired (grant/award) | +500K 2.9% of company | n/a | 500K | n/a | Sep 9, 25 |
Cohen Jacob D. Officer | Sold (automatic/other) | -200K 1.2% of company | n/a | n/a | n/a | Jun 5, 25 |
Cohen Jacob D. Officer | Acquired (grant/award) | +200K 1.2% of company | added 33% | 805K | n/a | Jun 5, 25 |
D'Alessio Lorraine Pamela Director | Acquired (grant/award) | +25K 0.1% of company | added 100% | 37K | n/a | Apr 10, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $MGRX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $1.295/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$MGRX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$MGRX Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to MGRX
Comparable names in services-misc health & allied services, nec, closest in size first.
MGRX stock FAQ
Why is $MGRX up today?
MGRX is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 18 unusual-volume and momentum alerts on MGRX today, peaking at 23.0x its normal volume. Fresh from the SEC: MANGOCEUTICALS, INC. filed a Merger / acquisition communication (425). A material company disclosure like this is often the real catalyst behind a move of this size.
What is the MGRX stock price today?
MGRX last traded at $0.511, up 20.18% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does MGRX report earnings?
Mangoceuticals, Inc. Common Stock (MGRX) is next expected to report earnings on Thursday, August 13, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live MGRX alerts?
The MGRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MGRX 165 times in the last 30 days.
What exchange is MGRX on?
MGRX (Mangoceuticals, Inc. Common Stock) trades on XNAS, with a market cap of about $7M in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector.
Is MGRX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MGRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.